Novel alpha-1 antitrypsin variant, preparation method thereof and use thereof
AssigneeAlteogen, Inc.
InventorsSoon Jae Park, Hye-Shin Chung, Sang Mee Lee, Ji-Sun Kim
Life of this patent
Estimating the term…
Abstract
A novel alpha-1 antitrypsin variant, a method of preparing the same, and use thereof are provided. The alpha-1 antitrypsin variant has excellent stability in the body and maintains an inhibitory effect on elastase activities because the blood half-life (t1/2) and the area under blood drug concentration vs. time curve (AUC) are remarkably increased by adding an N-glycosylation site in animal cells through amino acid mutation between 1st and 25th positions of the N-terminus of alpha-1 antitrypsin. Therefore, the alpha-1 antitrypsin variant can be useful in preventing or treating alpha-1 antitrypsin deficiency.
Claims12
An alpha-1 antitrypsin variant prepared by substituting an amino acid at a specific site between 1st and 25th positions of the N-terminus of alpha-1 antitrypsin in order to add a glycosylation site.
Dependencies are inferred from the claim text.